The study of Immucyst for the prophylaxis of the superficial bladder cancer at a intermediate risk for the intravesical recurrence
Not Applicable
Recruiting
- Conditions
- superficial bladder cancer at the intermediate risk
- Registration Number
- JPRN-UMIN000001321
- Lead Sponsor
- Department of Urology, Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
1) The history or the presence of Invasive bladder cancer with T2 or more 2) untreated CIS 3) single tumor of Ta, G1 4) tumor of T1,G3 5) associated malignant tumors at the upper urinary tract and/or the urethra 6) the presence of metastases to the lymph nodes and/or the distant organ or active double cancer 7) The presence of active tuberculosis infection with or without the anti-tuberculosis therapy 8) Contraindication for BCG instillation therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method